Stem cell eye drops aim to heal stubborn corneal wounds
NCT ID NCT06919081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether eye drops made from stem cell secretions can help heal persistent corneal defects that haven't improved with standard treatments. About 24 adults with chronic corneal damage will receive either the active drops or a placebo for 8 weeks. The main goal is to see if the drops improve the eye's surface barrier and heal the defect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL EPITHELIAL DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.